Our Latest

24 newest posts

Situation

PostNovember 12, 2026

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease

HNHealthcare NewsNovember 12, 2026

Assessment

All 40 →

Press release
World Cord Blood Day 2026 Spotlights Life-Saving Combo: Newborn Screening + Cord Blood Transplants for SCID & Krabbe
Press release · November 12, 2026
Post
POTS Phase 2 Trial Shows Baloncibart, a First-in-Class NPR1 Blocking Antibody, Reduced Orthostatic Heart Rate and Improved Orthostatic Symptoms
Post · November 12, 2026
Press release
Colorectal Cancer Alliance Rallies Support for Bipartisan Bill to Create First National Plan on Young Adult Cancers
Press release · November 12, 2026
Press release
American Seniors Housing Association Celebrates 35 Years of Leadership with Commemorative Book
Press release · November 12, 2026
Post
Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Post · November 12, 2026
Post
Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day
Post · November 12, 2026
Post
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
Post · November 12, 2026
Press release
The Radiology Group expands into Washington, Launches WeCare! platform to support Rural Washington hospitals
Press release · November 12, 2026
Post
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Post · November 12, 2026
Post
Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
Post · November 12, 2026
Post
Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
Post · November 12, 2026
Post
Crescent Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Post · November 12, 2026

Post
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Post · November 12, 2026
Post
YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease
Post · November 12, 2026
Post
Anaptys Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Post · November 12, 2026
Post
Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results
Post · November 12, 2026
Post
Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights
Post · November 12, 2026
Post
Royalty Pharma to present at the UBS Global Biopharma Conference
Post · November 12, 2026
Post
BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results
Post · November 12, 2026
Post
Biomea Fusion to Participate in Upcoming Investor Conferences
Post · November 12, 2026
Post
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Post · November 12, 2026
Post
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Post · November 12, 2026
Post
ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing
Post · November 12, 2026

View all Posts502 posts on Healthcare News